Message #14 From:
NewsBot Date: July 21, 2006 09:59:00 AM
EMFP News Emergency Filtration Products Reports on Filter Production, Comments on Recent Decline in Stock Price
HENDERSON, Nev.--(BUSINESS WIRE)--July 21, 2006--Emergency Filtration Products Inc. (EFP) (OTCBB: EMFP) today reported its NanoMask filter production for the first and second quarter 2006. Large filters are those designed for a standard adult NanoMask, while the small filters are designed for the children's NanoMask.
NanoMask Filter Production 1Q 2Q
----- -----
Nogales
============================================
Large Filter 1,008,000 2,603,000
Small Filter 588,000
Total 1,008,000 3,191,000
Henderson
============================================
Large Filter 1,902,576 1,322,960
Small Filter
Total 1,902,576 1,322,960
Combined Locations
============================================
Large Filter 2,910,576 3,925,960
Small Filter 0 588,000
Total 2,910,576 4,513,960
Combined production for the second quarter ended June 30, 2006, increased 55% to 4,513,960 from 2,910,576 in the first quarter ended March 31, 2006. Production at the company's Nogales, Mexico, facility increased 217%, while production at the company's Henderson, Nev., facility decreased 30%. The decrease in production in Henderson is the result of the company's ongoing efforts to shift production to Nogales in order to realize significant improvements in operating efficiencies and cost reductions.
Separately, the company announced that it knows of no fundamental reason for the recent decline in the price of the stock. The company continues to experience positive developments in its operations. The company expects to announce its second quarter results as soon as possible, and is planning to host a conference call to discuss its second quarter financial statements and year-to-date progress.
About Emergency Filtration Products Inc.
EFP (http://www.emergencyfiltration.com/) is an air filtration products manufacturer whose patented 2H Technology(TM) filter system has produced filtration efficiencies of "greater than 99.99%" at a particulate size of 0.027 microns. Its initial products were developed for the medical market: the Vapor Isolation Valve(TM) and RespAide(R) CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases; and the 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received FDA approval. The company also markets an Automated External Defibrillator Prep Kit featuring RespAide; and the NanoMask(R), a nanotechnology enhanced environmental mask. In addition to filtration products, the company supplies Superstat(R), a modified hemostatic collagen, to the U.S. military for surgery and extreme wound care.
Safe Harbor Statement
This release may contain statements that are forward looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future results of the company could differ significantly from such forward-looking statements. Sales may be dependent on the success of future marketing campaigns, the signing of definitive agreements with additional distributors, and both the perceived need for EFP's products and the competitive performance of such products in the marketplace.
